Acorda Therapeutics Reports Third Quarter 2013 Financial Results

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced its financial results for the third quarter ended September 30, 2013.

“We are pleased with the continued growth and progress of the Company. AMPYRA net sales for the third quarter were in line with our expectations and we are encouraged by fourth quarter sales to date. We also have a strong cash position of approximately $350 million.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC